3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
8
Terminated
6
Unknown
3
Recruiting
2
Active not recruiting
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Interventions
Paclitaxel
9
Carboplatin
8
Bevacizumab
8
fluzoparib
5
olaparib
3
Topotecan
3
Gemcitabine
3
liposomal doxorubicin
2
famitinib
2
apatinib
2
Oxaliplatin
2
Magnetic Resonance Spectroscopy
2
Indocyanine Green
2
Drug Therapy
2
Cisplatin
2
trametinib
1
senaparib
1
pembrolizumab
1
niraparib
1
montelukast
1
irinotecan sucrosofate
1
fludarabine
1
durvalumab
1
dalpiciclib
1
dabrafenib
1
ceralasertib
1
anlotinib
1
aldesleukin
1
Ultrasonography, Doppler
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Ovarian Neoplasms
×
1-dodecylpyridoxal
×
Clear all
NCT07564141
2026-06-03
RAINFOLâ„¢-07
Genmab
Phase 3
Not yet recruiting
688 enrolled